<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T13:03:17Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/9zz43g76pz.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/9zz43g76pz.1</identifier>
                <datestamp>2025-08-19T20:34:12Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Liu, Jie</dc:creator>
    <dc:title>Poly (allylamine hydrochloride)-selenium Nanoparticles Inhibit Porcine Reproductive and Respiratory Syndrome Virus by Targeting DDX5 and Reactive Oxygen Species</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) remains a critical threat to the swine industry worldwide due to its rapid evolution and limited vaccine efficacy. In this study, we synthesized and characterized poly (allylamine hydrochloride)-selenium nanoparticles (PAH-Se NPs) and evaluated their antiviral activity against PRRSV in vitro and the underlying mechanism. PAH-Se NPs exhibited uniform spherical morphology with average hydrodynamic diameter of 118 nm and excellent colloidal stability with a zeta potential of +50.7 mV. Cytotoxicity assays demonstrated low toxicity of PAH-Se NPs in MARC-145 cells with a CC50 of 40.24 μg/mL, indicating favorable biocompatibility. Multiple complementary assays, including viral RNA quantification, cell viability restoration, plaque assays, N protein expression analyses, and indirect immunofluorescence assay, showed that PAH-Se NPs could significantly inhibit PRRSV replication in a dose-dependent manner, with an IC50 of 0.076 μg/mL. Moreover, this inhibition was equally effective against other sub-genotypes of PRRSV, including VR2332 and NADC30-like variants, as well as the DNA virus PCV-2, indicating the broad-spectrum anti-microbial properties of PAH-Se NPs. Mechanistic studies indicated that PAH-Se NPs target viral invasion and replication by down-regulating the host factor DDX5, which interacts with PRRSV Nsp9 to facilitate viral RNA synthesis, and suppressed PRRSV-induced reactive oxygen species (ROS) accumulation. </dc:description>
    <dc:subject>Viral Disease</dc:subject>
    <dc:subject>Antiviral Therapy</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/9zz43g76pz.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/9zz43g76pz.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/9zz43g76pz</dc:relation>
    <dc:date>2025-08-19T20:34:12Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
